AU4473597A - Novel expression vectors for production of foreign proteins as soluble forms - Google Patents
Novel expression vectors for production of foreign proteins as soluble formsInfo
- Publication number
- AU4473597A AU4473597A AU44735/97A AU4473597A AU4473597A AU 4473597 A AU4473597 A AU 4473597A AU 44735/97 A AU44735/97 A AU 44735/97A AU 4473597 A AU4473597 A AU 4473597A AU 4473597 A AU4473597 A AU 4473597A
- Authority
- AU
- Australia
- Prior art keywords
- production
- expression vectors
- soluble forms
- foreign proteins
- novel expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1996/44010 | 1996-10-04 | ||
KR1019960044010A KR100203919B1 (en) | 1996-10-04 | 1996-10-04 | A novel expression vector which produces water soluble protein |
PCT/KR1997/000186 WO1998014591A1 (en) | 1996-10-04 | 1997-10-04 | Novel expression vectors for production of foreign proteins as soluble forms |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4473597A true AU4473597A (en) | 1998-04-24 |
AU725755B2 AU725755B2 (en) | 2000-10-19 |
Family
ID=19476265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44735/97A Ceased AU725755B2 (en) | 1996-10-04 | 1997-10-04 | Novel expression vectors for production of foreign proteins as soluble forms |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0871741A1 (en) |
KR (1) | KR100203919B1 (en) |
AU (1) | AU725755B2 (en) |
WO (1) | WO1998014591A1 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298000A (en) * | 1999-11-30 | 2001-06-06 | 上海博容基因开发有限公司 | Human class-II amino acyl-tRNA synthetase 9 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
CN1307106A (en) * | 2000-01-26 | 2001-08-08 | 上海博道基因技术有限公司 | Polypeptide-human type II aminoacyl-tRNA synthetase 75 and polynucleotide for coding said polypeptide |
AU2000261861A1 (en) * | 2000-07-28 | 2002-02-13 | Hanmi Pharm. Co., Ltd. | Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom |
KR20020010241A (en) * | 2000-07-28 | 2002-02-04 | 허영섭 | Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom |
KR100890579B1 (en) * | 2002-08-19 | 2009-04-27 | 프로테온 주식회사 | Method for preparation of recombinant protein using RNA binding protein as fusion partner |
KR100484653B1 (en) | 2004-05-06 | 2005-04-20 | 주식회사 대웅 | Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor |
KR101023518B1 (en) * | 2008-12-29 | 2011-03-21 | 고려대학교 산학협력단 | A preparation method of solubility recombinant protein by use of Aspartate carbamoyltransferase catalytic chain as a fusion expression partner |
WO2011139714A2 (en) | 2010-04-26 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
US8986681B2 (en) | 2010-04-27 | 2015-03-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases |
AU2011248614B2 (en) | 2010-04-27 | 2017-02-16 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
WO2011139853A2 (en) | 2010-04-28 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
CA2797374C (en) | 2010-04-29 | 2021-02-16 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
US9068177B2 (en) | 2010-04-29 | 2015-06-30 | Atyr Pharma, Inc | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
EP2563383B1 (en) | 2010-04-29 | 2017-03-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
CA2797977C (en) | 2010-05-03 | 2019-08-20 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
CN103108655B (en) | 2010-05-03 | 2017-04-05 | Atyr 医药公司 | Treatment, diagnosis and the innovation of antibody compositions related to the protein fragments of seryl tRNA synzyme finds |
WO2011139986A2 (en) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
JP6008841B2 (en) | 2010-05-03 | 2016-10-19 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of methionyl tRNA synthetase |
JP6008843B2 (en) | 2010-05-04 | 2016-10-19 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutamyl-prolyl tRNA synthetase |
EP2566499B1 (en) | 2010-05-04 | 2017-01-25 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
CA2799197C (en) | 2010-05-14 | 2019-10-29 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
CA2799480C (en) | 2010-05-17 | 2020-12-15 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
US8962560B2 (en) | 2010-06-01 | 2015-02-24 | Atyr Pharma Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases |
EP2593126B1 (en) | 2010-07-12 | 2017-09-20 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
CN103118695B (en) | 2010-07-12 | 2016-08-03 | Atyr医药公司 | The discovery for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Glycyl-tRNA synthetase |
AU2011279392C1 (en) | 2010-07-12 | 2017-06-15 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases |
US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
EP2608801B1 (en) | 2010-08-25 | 2019-08-21 | aTyr Pharma, Inc. | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
ES2645019T3 (en) | 2010-10-06 | 2017-12-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic and antibody compositions related to tryptophanil-tRNA synthetases protein fragments |
WO2013022982A2 (en) | 2011-08-09 | 2013-02-14 | Atyr Pharma, Inc. | Pegylated tyrosyl-trna synthetase polypeptides |
KR101360375B1 (en) * | 2011-08-19 | 2014-02-10 | 연세대학교 산학협력단 | Recombinant E. coli producing soluble BMP-2 and method for producing soluble BMP-2 using the same |
WO2013086228A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Pegylated aspartyl-trna synthetase polypeptides |
US9816084B2 (en) | 2011-12-06 | 2017-11-14 | Atyr Pharma, Inc. | Aspartyl-tRNA synthetases |
CN104220461A (en) | 2011-12-29 | 2014-12-17 | Atyr医药公司 | Aspartyl-trna synthetase-fc conjugates |
EP2970921B1 (en) | 2013-03-15 | 2018-09-19 | aTyr Pharma, Inc. | Histidyl-trna synthetase-fc conjugates |
KR101908438B1 (en) * | 2016-02-05 | 2018-10-16 | (주)피앤피바이오팜 | A MANUFACTURING METHOD FOR SOLUBLE AND ACTIVE RECOMBINANT PROTEIN USING Aminoacyl tRNA synthetase N-terminal domain AS FUSION PARTNER AND A PRODUCT THEREOF |
KR101816081B1 (en) * | 2016-06-03 | 2018-01-08 | 연세대학교 산학협력단 | Antigen protein containing LysRS from Bordetella pertussis and detection method for Pertussis using the same |
WO2018195338A1 (en) | 2017-04-20 | 2018-10-25 | Atyr Pharma, Inc. | Compositions and methods for treating lung inflammation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62278992A (en) * | 1986-05-28 | 1987-12-03 | Unitika Ltd | Production of diadenosine-tetraphosphate or derivative thereof |
-
1996
- 1996-10-04 KR KR1019960044010A patent/KR100203919B1/en not_active IP Right Cessation
-
1997
- 1997-10-04 EP EP97943210A patent/EP0871741A1/en not_active Withdrawn
- 1997-10-04 AU AU44735/97A patent/AU725755B2/en not_active Ceased
- 1997-10-04 WO PCT/KR1997/000186 patent/WO1998014591A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1998014591A1 (en) | 1998-04-09 |
KR100203919B1 (en) | 1999-06-15 |
AU725755B2 (en) | 2000-10-19 |
EP0871741A1 (en) | 1998-10-21 |
KR19980025768A (en) | 1998-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4473597A (en) | Novel expression vectors for production of foreign proteins as soluble forms | |
AU4816397A (en) | Process for bacterial production of polypeptides | |
HUP9900422A3 (en) | Novel protein and methods for the production of the same | |
AU7566396A (en) | Process for the preparation of peptides by way of streptavidin fusion proteins | |
AU7412196A (en) | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of beta-amyloid protein production | |
AU3549397A (en) | Over-expression of proteins | |
AU2548097A (en) | Formulations of ob protein | |
AU2953997A (en) | Production of apomictic seed | |
AU2713197A (en) | Process for stereoselective preparation of 4-acetoxyazetidinones | |
AU9450098A (en) | Production of esters | |
AU5678396A (en) | Methods of preparing soluble, oligomeric proteins | |
AU2978697A (en) | Novel peptide, process for the production of the same, and use of the same | |
AU1655997A (en) | Method for secretory production of protein | |
AU4208897A (en) | Oligocistronic expression system for the production of heteromeric proteins | |
AU2467395A (en) | Novel ophthalmologic uses of protein c | |
AU7300398A (en) | Process of preparing substituted acrylamides | |
AU8059391A (en) | Method of making peptides | |
AU5504999A (en) | Production of proteins | |
AU4380599A (en) | Methods for production of recombinant polypeptides | |
AU1073599A (en) | Production of kappa-casein macropeptide | |
AU4114697A (en) | Improved process for the production of adipoyl cephalosporins | |
AU2959397A (en) | Process for the preparation of hydrazine derivatives useful as intermediates for the preparation of peptide analogues | |
GB9714680D0 (en) | Recombinant production of proteins | |
AU6871996A (en) | Process for the production of water-absorbing compositions | |
AU7075498A (en) | Process for the preparation of trifluoroethoxyarenecarboxylic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |